Table 1.

Clinical characteristics of 22 eyes with ECE

Patient No.	Age/sex	Eye	Predisposing risk factors	C. a culture	Treatment	Initial VA	Last VA
1	41/M	OD	Intravenous corticosteroid	Vitreous (+)	IVI + vitrectomy	20/2000	20/400
2	29/F	OS	Intravenous antibiotics	Vitreous (+)	IVI + vitrectomy	20/2000	20/2000
3	28/M	OS	Endocarditis	blood (+)	IVI + vitrectomy	20/100	20/100
4	40/F	OS	Intravenous corticosteroid	Vitreous (+)	IVI + vitrectomy	HM	HM
5	58/M	OD	Intravenous corticosteroid	Vitreous (+)	IVI	20/200	20/63
		OS		Vitreous (+)	IVI	20/200	20/100
6	23/F	OS	Diabetes	Vitreous (+)	IVI + vitrectomy	HM	20/100
7	67/F	OS	Intravenous corticosteroid	Vitreous (+)	IVI + vitrectomy	CF	CF
8	49/F	OD	nephrolithotripsy	blood (+)	IVI	20/400	20/100
		OS			IVI	20/32	20/25
9	58/F	OD	Diabetes	Vitreous (+)	IVI + vitrectomy	20/2000	20/200
		OS		Vitreous (+)	IVI + vitrectomy	CF	CF
10	37/F	OD	Diabetes; nephritis	blood (+); midstream urine (+)	IVI	20/25	20/20
		OS			IVI + vitrectomy	LP	LP
11	51/F	OD	Intravenous antibiotics	Vitreous (+)	IVI + vitrectomy	CF	20/400
		OS		Vitreous (+)	IVI + vitrectomy	CF	CF
12	53/F	OS	ureterolithotripsy	blood (+)	IVI	20/63	20/50
13	39/M	OD	ureterolithotripsy	Vitreous (+)	IVI + vitrectomy	20/1000	20/1000
14	68/M	OD	nephrolithotripsy	blood (+); midstream urine (+)	IVI	20/100	20/63
		OS			IVI + vitrectomy	CF	20/160
15	59/F	OD	Gastrointestinal surgery	blood (+)	IVI	HM	HM
16	28/F	OD	Abortion	Vitreous (+)	IVI + vitrectomy	HM	CF

ECE Endogenous candida endophthalmitis, F. Female, M Male, OD Right eye, OS Left eye, C. a Candida albicans, IVI Intravitreal injection, VA Visual acuity, LP Light perception, HM Hand motion, CF Counting fingers